## ALGN: Align Technology, Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.95 indicates fundamental undervaluation. Caution: declining volume (51% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($148.71)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Align Technology to Announce Fourth Quarter and 2025 Results on February 4, 2026**
- Source: Business Wire | 20260102T133133 | Neutral | Relevance: 100%
- Align Technology, Inc. (Nasdaq: ALGN) is scheduled to release its fourth quarter and full year 2025 financial results on Wednesday, February 4, 2026, after the market closes. Following the release, the company will host a conference call at 4:30 p.m. ET to discuss these results. Additionally, Align Technology has provided anticipated earnings release dates for its fiscal year 2026 quarters.

**2. Align Technology to Announce Fourth Quarter and 2025 Results on February 4, 2026**
- Source: Yahoo Finance Singapore | 20260102T130709 | Neutral | Relevance: 100%
- Align Technology (Nasdaq: ALGN) is set to announce its fourth-quarter and full-year 2025 financial results on Wednesday, February 4, 2026, after market close. The company, a leading global medical device provider for digital orthodontics and restorative dentistry, will host a conference call and webcast to discuss these results. Align also provided anticipated earnings release dates for its fiscal year 2026.

**3. Align Technology Inc.: How a Clear Aligner Platform Became a Full-Funnel Orthodontic Ecosystem**
- Source: AD HOC NEWS | 20260102T060812 | Bullish | Relevance: 100%
- Align Technology Inc. has transformed clear aligners from a niche product into a comprehensive digital orthodontic platform, driven by its Invisalign system, iTero scanners, and ClinCheck software. This ecosystem integrates hardware, software, and AI to offer an end-to-end digital workflow, creating strong competitive advantages against rivals like 3M and Straumann. Align's focus on the professional channel and its data-driven approach position it as a leader in digital dentistry, influencing its stock valuation.

**4. Align Technology Inc.: How a Clear Aligner Platform Became a Full-Funnel Orthodontic Ecosystem**
- Source: AD HOC NEWS | 20260102T060724 | Bullish | Relevance: 100%
- Align Technology Inc. has transformed clear aligners from a niche product into a comprehensive digital orthodontic and restorative dentistry platform. The company's ecosystem integrates iTero scanners, ClinCheck software, and Invisalign clear aligners, creating a full-stack digital workflow that provides significant advantages over competitors. This robust, data-driven approach positions Align Technology as a leader in modern orthodontics, attracting both clinicians and investors despite market competition and economic sensitivities.

**5. Zacks Investment Ideas feature highlights: Deckers Brands, Nike, On Holdings and Align Technology**
- Source: The Globe and Mail | 20260101T001849 | Bullish | Relevance: 95%
- Zacks Investment Ideas highlights Deckers Brands (DECK), Nike (NKE), On Holdings (ONON), and Align Technology Inc. (ALGN) as potential investment opportunities for 2026. The article suggests focusing on strong, underperforming S&P 500 companies, presenting DECK and ALGN as "beaten-down" stocks with significant upside. It details the financial strength, market position, and growth outlooks for both Deckers Brands and Align Technology, arguing they are attractive buys despite recent stock declines.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $170 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.6% (+0.7%)
- Blackrock Inc.: 6.9% (-3.4%)
- Ninety One UK Ltd: 6.3% (+136.6%)
- Capital Internationa: 4.2% (+88.6%)
- State Street Corpora: 4.0% (-1.3%)

### Key Risks

1. High beta (1.86) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.95 indicates undervaluation relative to growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.3B |
| Beta | 1.86 |
| 52W Range | $122.00 - $237.23 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.95 |
| Forward P/E | 14.2 |
| Current P/E | 15.3 |
| YoY Growth | 7.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.9% over 5 days). Below STRENGTH zone by 5.6pp (needs >4.0% for momentum thesis). Underperforming sector by 3.3pp, stock-specific weakness. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram bearish (-1.34), momentum weakening. RSI neutral at 53. Volume at 51% of 20MA suggests lack of conviction. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.64% (CS: 22) | Neutral |
| RSI_14 | 52.7 | Neutral |
| MACD Histogram | -1.34 | Bearish |
| vs SMA20 | 0.978x | Below |
| vs SMA50 | 1.059x | Above |
| vs SMA200 | 0.981x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $156.03
- **Stop Loss:** $148.71 (4.7% risk)
- **Target:** $170.67 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 196
- **Position Value:** $30,581.88
- **Portfolio %:** 30.58%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-04 (Est: $2.96)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.41 | $2.61 | +8.4% |
| 2025Q2 | $2.57 | $2.49 | -3.3% |
| 2025Q1 | $1.99 | $2.13 | +7.1% |
| 2024Q4 | $2.45 | $2.44 | -0.4% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*